The BIM pro-apoptotic factor has been shown to play a critical role in glucocorticoid-induced apoptosis in normal and malignant lymphoid cells through its antagonistic role to the anti-apoptotic BCL2 protein that is increased by IL7/IL7R signaling in ETP-ALL [23]. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.